Frontiers in Pharmacology (Nov 2022)

Erratum: Efficacy and safety evaluations of anlotinib in patients with advanced non-small cell lung cancer treated with bevacizumab

  • Frontiers Production Office

DOI
https://doi.org/10.3389/fphar.2022.1092147
Journal volume & issue
Vol. 13

Abstract

Read online

No abstracts available.

Keywords